Publications
Pre-prints
Jia, K.M., Boyer, C., Bilinski, A. & Lipsitch, M. (2025). “Defining and Estimating Outcomes Directly Averted by a Vaccination Program when Rollout Occurs Over Time”. arXiv. https://doi.org/10.48550/arXiv.2509.05508
Boyer, C., Field, E., Lehrer, R., Morrison, A., & Piras, C. (2025). “Guy Talk: Catalyzing Peer Effects on IPV through Virtual Support Groups for Men”. https://sites.duke.edu/ericafield/files/2025/03/wp_2025_03_Guy_Talk_Peru.pdf
Zhang, Z., Boyer, C., Lipsitch, M. (2024). “Use of the test-negative design to estimate the protective effect of a scalar immune measure: A simulation analysis”. medRxiv. https://doi.org/10.1101/2024.11.22.24317757
Joshi, K., Kahn, R., Boyer, C., & Lipsitch, M. (2023). “Some principles for using epidemiologic study results to parameterize transmission models”. medRxiv. https://doi.org/10.1101/2023.10.03.23296455
Peer-reviewed publications
Methodological
Boyer, C., Li, K.Q., Shi, X., & Tchetgen Tchetgen, T. J. (2025). “Identification and estimation of vaccine effectiveness in the test-negative design under equi-confounding”. Epidemiology. In Press.
pre-print / repository Boyer, C., Dahabreh, I. J., & Steingrimsson, J. A. (2025). “Estimating and evaluating counterfactual prediction models”. Statistics in Medicine, 44(23-24), e70287. https://doi.org/10.1002/sim.70287
pre-print / repository Gago, J., Boyer, C., & Lipsitch, M. (2025). “How should we study the indirect effects of antimicrobial treatment strategies? A causal perspective”. Epidemiology. In Press.
pre-print Voter, S. C., Dahabreh, I. J., Boyer, C., Rahbar, H., Kontos, D., & Steingrimsson, J. A. (2025). “Counterfactual prediction from machine learning models: transportability and joint analysis for model development and evaluation using multi-source data”. Diagnostic and Prognostic Research, 9(22). https://doi.org/10.1186/s41512-025-00201-y
repository / pdf Jia, K. M., Boyer, C., Wallinga, J., & Lipsitch, M. (2025). “Causal Estimands for Analyses of Averted and Avertible Outcomes due to Infectious Disease Interventions”. Epidemiology, 36(3), 363-373. https://doi.org/10.1097/EDE.0000000000001839
pre-print / repository / pdf Boyer, C. & Lipsitch, M. (2025). “Emulating target trials of postexposure vaccines using observational data”. American Journal of Epidemiology, 194(7), 2037-2046. https://doi.org/10.1093/aje/kwae350
pre-print / repository / pdf Boyer, C., Rumpler, E., Kissler, S. M., & Lipsitch, M. (2022). “Infectious disease dynamics and restrictions on social gathering size”. Epidemics, 40, 100620. https://doi.org/10.1016/j.epidem.2022.100620
pre-print / repository / pdf
Randomized Trials
Boyer, C., Paluck, E. L., Annan, J., Nevatia, T., Cooper, J., Namubiru, J, Heise, L., & Lehrer, R. (2022) “Religious leaders can motivate men to cede power and reduce intimate partner violence: experimental evidence from Uganda”. PNAS. 119(31), e2200262119. https://doi.org/10.1073/pnas.2200262119
pre-analysis plan / repository / pdf Pinchoff, J., Boyer, C., Nag Chowdhuri, R., Smith, G., Chintu, N., & Ngo, T. D. (2019). “The evaluation of the Woman’s Condom marketing approach: What value did peer-led interpersonal communication add to the promotion of a new female condom in urban Lusaka?”. Plos one, 14(12), e0225832. https://doi.org/10.1371/journal.pone.0225832
Applied/Collaborative
Gasoyan, H., Butsch, W. S., Schulte, R., Casacchia, N. J., Le, P., Boyer, C., … & Rothberg, M. B. (2025). “Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status”. Obesity, 33(9), 1657-1667. https://doi.org/10.1002/oby.24331
Rosen, J. B., Arciuolo, R. J., Pathela, P., Boyer, C., Baumgartner, J., Latash, J., Malec, L., Lee, E. H., Reddy, V., King, R., Edward Real, J., Lipsitch, M., & Zucker, J. R. (2024). “JYNNEOS™ effectiveness as post-exposure prophylaxis against mpox: Challenges using real-world outbreak data”. Vaccine, 42(3), 548-555. https://doi.org/10.1016/j.vaccine.2023.12.066
pdf Chatterji, S., Boyer, C., Sharma, V., Abramsky, T., Levtov, R., Doyle, K., Harvey, S., & Heise, L. (2023). “Optimizing the Construction of Outcome Measures for Impact Evaluations of Intimate Partner Violence Prevention Interventions.” Journal of Interpersonal Violence, 38(15-16), 9105-9131. https://doi.org/10.1177/08862605231162887
pre-print / pdf NCD Risk Factor Collaboration (NCD-RisC). (2021) “Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants”. The Lancet. 398(10304), 957–980. https://doi.org/10.1016/S0140-6736(21)01330-1
pdf